CDK inhibitor AT7519M
Term · Oncology and biomedicine · MLC-T-ONC-001536
A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called AT7519M.
| Identifier | MLC-T-ONC-001536 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | AT7519M |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001536",
"term": "CDK inhibitor AT7519M",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called AT7519M.",
"synonyms": [
"AT7519M"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/cdk-inhibitor-at7519m/"
}
Record 4,462 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.